| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.09 | 0.1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.095 | 0.1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |